Invention Grant
- Patent Title: Kinase inhibitor compounds
-
Application No.: US13349222Application Date: 2012-01-12
-
Publication No.: US08524709B2Publication Date: 2013-09-03
- Inventor: Congxin Liang , Ming Qi , Shu Gao , Zhigang Li
- Applicant: Congxin Liang , Ming Qi , Shu Gao , Zhigang Li
- Applicant Address: US FL West Palm Beach
- Assignee: Tyrogenex, Inc.
- Current Assignee: Tyrogenex, Inc.
- Current Assignee Address: US FL West Palm Beach
- Agency: Edwards Wildman Palmer LLP
- Agent Jeffrey D. Hsi
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; A61K31/404 ; A61K31/454 ; A61K31/506 ; A61K31/4545 ; C07D401/14 ; C07D413/14 ; C07D403/06
Abstract:
The invention relates to compounds, compositions comprising the compounds, and methods of using the compounds and compound compositions. The compounds, compositions, and methods described herein can be used for the therapeutic modulation of kinase-mediated processes, and treatment of disease and disease symptoms, particularly those mediated by certain kinase enzymes.
Public/Granted literature
- US20120115866A1 KINASE INHIBITOR COMPOUNDS Public/Granted day:2012-05-10
Information query
IPC分类:
